Journey Medical (DERM) vs Whitehawk Therapeutics (WHWK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Whitehawk Therapeutics (WHWK) has outperformed Journey Medical (DERM) over the past year, gaining 62.2% versus a loss of 16.4%. Whitehawk Therapeutics is the larger company by market cap ($200.7 million vs $178.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DERM | WHWK |
|---|---|---|
| Share price | $6.31 | $3.52 |
| Market cap | $178.10M | $200.67M |
| 1-day change | +6.05% | +1.44% |
| YTD return | -18.16% | +45.45% |
| 1-year return | -16.42% | +62.21% |
| 5-year return | — | -87.06% |
| EPS (TTM) | $-0.22 | $-1.15 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.56 | $5.50 |
| 52-week low | $4.31 | $1.87 |
| Distance from 52-week high | -33.96% | -35.94% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +117.91% | +119.03% |
| Average volume | 183.99K | 366.33K |
| Shares outstanding | 22.22M | 57.01M |
| Employees | 58 | 32 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- WHWK has outperformed DERM by 78.6 percentage points over the past year.
About Journey Medical
DERM stock →Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris.
Health Care · Biotechnology: Pharmaceutical Preparations · 58 employees
About Whitehawk Therapeutics
WHWK stock →Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 32 employees
DERM vs WHWK FAQ
Which is bigger, Journey Medical or Whitehawk Therapeutics?
Whitehawk Therapeutics (WHWK) is larger, with a market capitalization of $200.67M compared with $178.10M for Journey Medical (DERM).
Which stock has performed better over the past year, DERM or WHWK?
WHWK returned +62.21% over the past 12 months, compared with -16.42% for DERM (price return, excluding dividends). Past performance does not predict future results.
Are Journey Medical and Whitehawk Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.